FONAR CORP (FONR) Stock Fundamental Analysis
USA - NASDAQ:FONR - US3444374058 - Common Stock
14.87 USD
-0.15 (-1%)
14.87 USD
0 (0%)
Taking everything into account, FONR scores 5 out of 10 in our fundamental rating. FONR was compared to 189 industry peers in the Health Care Equipment & Supplies industry. While FONR has a great health rating, its profitability is only average at the moment. FONR is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year FONR was profitable.
In the past year FONR had a positive cash flow from operations.
In the past 5 years FONR has always been profitable.
Each year in the past 5 years FONR had a positive operating cash flow.
1.2 Ratios
FONR has a better Return On Assets (3.60%) than 78.31% of its industry peers.
Looking at the Return On Equity, with a value of 4.52%, FONR is in the better half of the industry, outperforming 75.66% of the companies in the same industry.
FONR's Return On Invested Capital of 4.37% is fine compared to the rest of the industry. FONR outperforms 74.60% of its industry peers.
The Average Return On Invested Capital over the past 3 years for FONR is below the industry average of 9.08%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.6% | ||
| ROE | 4.52% | ||
| ROIC | 4.37% |
ROA(3y)4.2%
ROA(5y)4.71%
ROE(3y)5.35%
ROE(5y)6.16%
ROIC(3y)5.58%
ROIC(5y)6.68%
1.3 Margins
The Profit Margin of FONR (7.48%) is better than 78.31% of its industry peers.
FONR's Profit Margin has declined in the last couple of years.
FONR has a better Operating Margin (11.11%) than 78.31% of its industry peers.
FONR's Operating Margin has declined in the last couple of years.
FONR's Gross Margin of 41.11% is on the low side compared to the rest of the industry. FONR is outperformed by 64.55% of its industry peers.
In the last couple of years the Gross Margin of FONR has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.11% | ||
| PM (TTM) | 7.48% | ||
| GM | 41.11% |
OM growth 3Y-21%
OM growth 5Y-7.01%
PM growth 3Y-14.56%
PM growth 5Y-3.61%
GM growth 3Y-5.13%
GM growth 5Y-3.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FONR is destroying value.
The number of shares outstanding for FONR has been reduced compared to 1 year ago.
The number of shares outstanding for FONR has been reduced compared to 5 years ago.
FONR has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.60 indicates that FONR is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.60, FONR is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
FONR has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
FONR's Debt to FCF ratio of 0.05 is amongst the best of the industry. FONR outperforms 94.71% of its industry peers.
FONR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, FONR is in the better half of the industry, outperforming 74.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Altman-Z | 2.6 |
ROIC/WACC0.5
WACC8.74%
2.3 Liquidity
FONR has a Current Ratio of 8.45. This indicates that FONR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 8.45, FONR belongs to the best of the industry, outperforming 89.95% of the companies in the same industry.
FONR has a Quick Ratio of 8.28. This indicates that FONR is financially healthy and has no problem in meeting its short term obligations.
FONR has a Quick ratio of 8.28. This is amongst the best in the industry. FONR outperforms 91.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 8.45 | ||
| Quick Ratio | 8.28 |
3. Growth
3.1 Past
FONR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.77%.
Measured over the past 5 years, FONR shows a small growth in Earnings Per Share. The EPS has been growing by 0.90% on average per year.
FONR shows a small growth in Revenue. In the last year, the Revenue has grown by 1.42%.
The Revenue has been growing slightly by 4.02% on average over the past years.
EPS 1Y (TTM)-19.77%
EPS 3Y-11.06%
EPS 5Y0.9%
EPS Q2Q%-11.84%
Revenue 1Y (TTM)1.42%
Revenue growth 3Y2.25%
Revenue growth 5Y4.02%
Sales Q2Q%5.14%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 12.82, which indicates a correct valuation of FONR.
Based on the Price/Earnings ratio, FONR is valued cheaply inside the industry as 87.83% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.03. FONR is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.82 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FONR indicates a rather cheap valuation: FONR is cheaper than 97.88% of the companies listed in the same industry.
FONR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. FONR is cheaper than 95.77% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.6 | ||
| EV/EBITDA | 2.31 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)14.23
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for FONR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
14.87
-0.15 (-1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners47.25%
Inst Owner Change0.92%
Ins Owners5.07%
Ins Owner Change0%
Market Cap93.83M
Revenue(TTM)104.35M
Net Income(TTM)7.81M
Analysts0
Price TargetN/A
Short Float %0.65%
Short Ratio2.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.82 | ||
| Fwd PE | N/A | ||
| P/S | 0.9 | ||
| P/FCF | 12.6 | ||
| P/OCF | 8.33 | ||
| P/B | 0.54 | ||
| P/tB | 0.57 | ||
| EV/EBITDA | 2.31 |
EPS(TTM)1.16
EY7.8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.18
FCFY7.94%
OCF(TTM)1.79
OCFY12.01%
SpS16.54
BVpS27.35
TBVpS26.2
PEG (NY)N/A
PEG (5Y)14.23
Graham Number26.72
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.6% | ||
| ROE | 4.52% | ||
| ROCE | 5.81% | ||
| ROIC | 4.37% | ||
| ROICexc | 6.09% | ||
| ROICexgc | 6.42% | ||
| OM | 11.11% | ||
| PM (TTM) | 7.48% | ||
| GM | 41.11% | ||
| FCFM | 7.14% |
ROA(3y)4.2%
ROA(5y)4.71%
ROE(3y)5.35%
ROE(5y)6.16%
ROIC(3y)5.58%
ROIC(5y)6.68%
ROICexc(3y)7.78%
ROICexc(5y)9.2%
ROICexgc(3y)8.22%
ROICexgc(5y)9.77%
ROCE(3y)7.41%
ROCE(5y)8.87%
ROICexgc growth 3Y-21.28%
ROICexgc growth 5Y-6.2%
ROICexc growth 3Y-21.03%
ROICexc growth 5Y-5.92%
OM growth 3Y-21%
OM growth 5Y-7.01%
PM growth 3Y-14.56%
PM growth 5Y-3.61%
GM growth 3Y-5.13%
GM growth 5Y-3.63%
F-Score7
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 81.24% | ||
| Cap/Sales | 3.66% | ||
| Interest Coverage | 453.04 | ||
| Cash Conversion | 69.13% | ||
| Profit Quality | 95.41% | ||
| Current Ratio | 8.45 | ||
| Quick Ratio | 8.28 | ||
| Altman-Z | 2.6 |
F-Score7
WACC8.74%
ROIC/WACC0.5
Cap/Depr(3y)64.91%
Cap/Depr(5y)77.48%
Cap/Sales(3y)2.95%
Cap/Sales(5y)3.54%
Profit Quality(3y)114.83%
Profit Quality(5y)119.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-19.77%
EPS 3Y-11.06%
EPS 5Y0.9%
EPS Q2Q%-11.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.42%
Revenue growth 3Y2.25%
Revenue growth 5Y4.02%
Sales Q2Q%5.14%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.86%
EBIT growth 3Y-19.22%
EBIT growth 5Y-3.28%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.88%
FCF growth 3Y-11.29%
FCF growth 5Y-10.21%
OCF growth 1Y-20.07%
OCF growth 3Y-9.7%
OCF growth 5Y-11.2%
FONAR CORP / FONR FAQ
Can you provide the ChartMill fundamental rating for FONAR CORP?
ChartMill assigns a fundamental rating of 5 / 10 to FONR.
Can you provide the valuation status for FONAR CORP?
ChartMill assigns a valuation rating of 4 / 10 to FONAR CORP (FONR). This can be considered as Fairly Valued.
Can you provide the profitability details for FONAR CORP?
FONAR CORP (FONR) has a profitability rating of 5 / 10.
How financially healthy is FONAR CORP?
The financial health rating of FONAR CORP (FONR) is 8 / 10.